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Abstract 
Background: Management of congestive heart failure (CHF) is dependent on clinical assessments of volume status, 
which are subjective and imprecise. Point-of-care ultrasound (POCUS) is useful in the diagnosis of CHF, but how 
POCUS findings correlate with therapy remains unknown. This study aimed to determine whether the changes in 
clinical evaluation of CHF with treatment are mirrored with changes in the number of B lines on lung ultrasound (LUS) 
and inferior vena cava (IVC) size. In this prospective observational study, investigators performed serial clinical and 
ultrasound assessments within 24 h of admission (T1), day 1 in hospital (T2) and within 24 h of discharge (T3). Clinical 
assessments included an evaluation of the jugular venous distension (JVD), hepatojugular reflux (HJR), pulmonary 
rales and a clinical congestion score was calculated. Ultrasound assessment included the IVC size and collapsibility, 
and the number of B lines in an 8-point scan.
Results: Fifty consecutive patients were recruited with a mean age of 71.2 years (SD 12.7). Mean clinical congestion 
score on admission was 5.6 (SD 1.4) and declined significantly over time to 1.3 (0.91), as did the JVP, HJR and pulmo-
nary rales. No significant changes were found in the IVC size between T1 [1.9 (0.65)] and T3 [2.0 (0.50)] or in the IVC 
collapsibility index [T1 0.3 (0.19) versus T3 0.25 (0.16)]. The mean number of B lines decreased from 11 (6.1) at T1 to 8.3 
(5.5) at T3, although this decrease did not reach statistical significance. Spearman correlation between JVP and HJR 
versus IVC collapsibility and total B lines did not yield significant results.
Conclusions: Clinical exam findings correlate over time during the management of CHF, whereas LUS and IVC results 
did not. The number of B lines did decrease with therapy, but did not reach statistical significance likely because the 
sampled population was small and had only mild heart failure. Further studies are warranted to further explore the 
use of lung ultrasound in this patient population.
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Background
Cardiovascular disease is the leading cause of mortality, 
representing 29% of all deaths, and costs the healthcare 
system 20.9 billion dollars annually in North America 
[1]. Congestive heart failure (CHF) is a complex clinical 
syndrome characterized by recurrent episodes of acute 
decompensation, requiring frequent hospitalizations and 
readmissions [2]. The diagnosis and management of CHF 
remain a clinical challenge; decisions are based on clini-
cal assessments of volume status, which are used to esti-
mate cardiac filling pressures [3]. Chest X-ray (CXR) has 
traditionally been used to suggest pulmonary congestion, 
but assessments can be subjective [4] and lack sensitivity 
and specificity [5]. Recently, serial assessments of brain 
natriuretic peptide (BNP) have been shown to correlate 
with the degree of hemodynamic congestion [6] and may 
be a reliable tool to guide management in heart failure 
patients [7].
The gold standard for determining cardiac conges-
tion is cardiac catheterization with determination of 
right atrial and left atrial pressures, as estimated by the 
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pulmonary capillary wedge pressures. These tests are 
invasive, time consuming and carry risk, and are not 
typically performed in patients admitted with decom-
pensated heart failure [8]. As a result, physicians rely on 
clinical assessments to diagnose elevated cardiac filling 
pressures. Clinical evaluation, however, correlates poorly 
with invasive hemodynamics [9] and the physical exam 
lacks sensitivity and specificity for the diagnosis of heart 
failure, limiting its clinical utility [10].
Point of care ultrasound (POCUS) has been developed 
as an easy-to-learn, rapid, portable, and non-invasive 
adjunct to physical examination. Previous studies have 
shown that inferior vena cava size correlates with right 
atrial pressure and pulmonary capillary wedge pressure 
with good sensitivity and specificity [11, 12], and outper-
forms the physical exam in the detection of an elevated 
jugular venous pressure [13]. However, IVC as a surro-
gate for volume status has been increasingly questioned, 
as the correlation to CVP has been variable [14]. How-
ever, the American Society of Echo guidelines still rec-
ommend its use as a non-invasive measurement of CVP 
[15].
Similarly, lung ultrasound and B lines, an artifact rep-
resenting extravascular lung water, similarly correlate 
significantly with pulmonary artery systolic pressure [16] 
and outperform classical signs and symptoms of con-
gestion [17]. Both lung [18, 19] and vascular ultrasound 
[20–22] have been shown to be helpful in the assessment 
of undifferentiated dyspnea and in the diagnosis of heart 
failure. It is not clear how POCUS findings change with 
treatment.
Methods
The primary objective of the current study is to compare 
serial lung and vascular ultrasound exam with clinical 
findings upon CHF treatment. The secondary objective 
was to explore the relationship between the severity of 
ultrasound-measured degree of congestion and length of 
hospital stay, hospital readmission and mortality.
The current study recruited consecutive patients with 
a clinical diagnosis of left-sided congestive heart failure 
who require admission to the cardiology service, the 
admitting cardiology team having made the diagnosis. 
All hospitalized, spontaneously breathing adult patients, 
between the ages of 18 and 90, with an admitting diagno-
sis of either systolic or diastolic left-sided heart failure as 
per the admitting cardiologist were included. Exclusion 
criteria were as follows: patients undergoing invasive ven-
tilation, patients with a primary diagnosis of right-sided 
heart failure, patients with active lung cancer, pulmonary 
fibrosis, interstitial lung disease, or pneumonia, patients 
who we are unable to have an ultrasound within the first 
24 h of admission and patients who are not competent to 
sign the consent form. Patients underwent serial clinical 
and ultrasound assessments at three time points: within 
24 h of admission (T1), day 1 of hospitalization (T2), and 
within 24  h prior to discharge (T3), for a total of three 
separate clinical and ultrasound exams (Fig. 1). The clini-
cal assessments including the physical exam were per-
formed by a senior resident in internal medicine and a 
senior critical care fellow. The assessors were aware of the 
time point of assessment.
Baseline patient demographics, including age, weight, 
sex, medical comorbidities, and etiology of heart fail-
ure were recorded from chart review. Laboratory values 
including hemoglobin, renal function and troponin val-
ues on admission were recorded from a chart review. Left 
ventricular ejection fraction (LVEF), diastolic function and 
valvulopathy were obtained from the most recent echocar-
diogram or during the current hospitalization. Chest X-ray 
(CXR) on admission was reviewed and graded by resident 
authors after they performed the clinical and ultrasound 
assessment as having interstitial edema or alveolar edema, 
where alveolar edema indicates more significant pulmo-
nary congestion. Three months following discharge, a 
chart review was performed to assess for length of hospital 
stay, hospital readmissions and 90-day mortality. The hos-
pital ethics committee approved the current study.
Clinical assessment
The Killip and clinical congestion score (CCS) were cal-
culated for each patient at across the three time points. 
The Killip score (0–4) [23] was calculated to grade the 
severity of heart failure, with 0 indicating no heart failure 
and 4 indicating cardiogenic shock. Although this score 
has been designed specifically in the setting of acute 
myocardial infarction, it was used in this study as it is a 
widely known descriptor of the severity of heart failure.
Cardiology 
admission for CHF 
(Day 0)
•< 24 Hrs after admission:
•Patient approached for enrollement (in emergency room or cardiac care 
unit)
•Informed consent established
•Initial clinical and ultrasound evaluation
Day 1 of 
hospitalization
•Repeat clinical and ultrasound evaluation
Day of discharge
•Within 24 hrs of discharge
•Repeat clinical and ultrasound evaluation
Fig. 1 Study design with three separate time points for ultrasound 
and clinical examination
Page 3 of 7Spevack et al. Crit Ultrasound J  (2017) 9:7 
The clinical congestion score (CCS) [24] was calculated 
based on pulmonary rales (scored 0–4), central venous 
pressure elevation (scored 0–4), S3 (presence 1, absence 
0) and orthopnea (scored 0–4). The CCS has a maximum 
score of 13, where higher scores indicate more severe 
heart failure. The CCS was validated on an outpatient 
population with stable heart failure, and has been shown 
to correlate with echocardiographic findings of increased 
filling pressures [19].
Specifically, the following symptoms and physical exam 
findings were graded for the above scores as follows: the 
presence of dyspnea and PND was graded as present (1) 
or absent (0). Orthopnea was graded between 0 and 4, 
with a score of 0 indicating the need of one pillow during 
sleep, and 4 indicating at least one night spent sleeping 
in a sitting position. Central venous pressure elevation 
was graded as 0 if the crests of neither the internal nor 
the external jugular vein are visible above the clavi-
cle, and 4 if the crests are visible at the earlobe with the 
patient assessed at 30–45°. The hepatojugular reflux was 
recorded as present (1) or absent (0). Rales/crackles were 
graded as being absent (0), present in less than 50% of 
the lung field (1), or more than 50% of the lung field (2). 
Peripheral edema was graded between 0 and 4 according 
to the depth of indentation at the ankle.
Ultrasound assessment
The POCUS ultrasound assessment was performed with 
the Zonare zone system (Zonare Medical Systems Inc, 
Mountain View, Ca, USA). Two authors (RS and MS) col-
lected the ultrasound data after a 3-h training session and 
10 supervised scans with an intensive care specialist with 
advanced cardiac echo and formal training in lung ultra-
sound prior to enrollment of patients. Brennan et al. [25] 
have shown that internal medicine residents with mini-
mal training, including 4 h of formal didactic ultrasound 
teaching, and 20 sonographer supervised acquisitions 
were able to obtain adequate images of the IVC in 90% 
of patients. Each patient underwent serial scans at the 
time of the clinical assessments. Two authors (MS and 
JL) blinded to clinical information analyzed the stored 
images. A priori it was established that findings on vas-
cular and LUS were not disclosed to the treating team 
unless they found a significant unexpected life-threat-
ening diagnoses, such as venous thrombus, complex 
pleural effusion suggestive of empyema, pneumothorax 
or cardiac tamponade. As a result, no treatment decisions 
regarding the patient’s heart failure were made based on 
the ultrasound findings.
The IVC was analyzed in the long axis via the subcos-
tal window using a 4-MHz phased-array ultrasound 
transducer. The diameter of the intra-hepatic IVC within 
1–2 cm of the right atrium and the response of the IVC to 
an inspiratory maneuvre was measured and recorded. The 
size of the IVC on expiration was recorded, and the IVC 
collapsibility index was calculated as (IVC size on expira-
tion − IVC size on inspiration)/IVC size on expiration.
All lung ultrasounds were performed using a 6-MHz 
curved array probe and a 3-s clip was recorded in each 
quadrant. A bilateral 8-point LUS examination was per-
formed to assess for B lines following the International 
consensus guidelines [8]. An oblique intercostal view 
was obtained to maximize the number of B lines, and the 
actual count was made at the moment the most B lines 
were visualized.
Data analysis
Clinical and ultrasound variables were analyzed using a 
paired t test. Pearson correlations were used to compare 
clinical and ultrasound variables. The impact of ultra-
sound and clinical assessments on hospital LOS and 
90-day mortality was evaluated using univariate and mul-
tivariate analyses.
Results
Fifty patients were recruited in the study. Five patients 
were excluded because they had a primary diagnosis of 
pneumonia complicated by pulmonary edema, and one 
patient was excluded because CHF was not the final diag-
nosis. Mean age was 77 (SD 12.7); 52% were males. The 
mean LVEF was 47.8%, and mean highly sensitive tro-
ponin T (Roche) value on admission was 293  ng/L (SD 
824). The etiology of CHF was ischemic (33%), followed 
by valvular (26%) and hypertensive (6%), whereas 22% 
had a new diagnosis of CHF when they were recruited 
(Table 1). Median hospital length of stay was 7 days (IQR 
5–13), 24% of patients were readmitted within 30 days of 
discharge and there was a 12% mortality rate at 90 days. 
Seventy-two percent of patients completed the three 
scans.
Table 1 Baseline clinical characteristics at time of recruitment
Mean age Sex (% male) LVEF (%) Diastolic dys-
function (%)







Mean or  % 77.2 52.3% 47 32.6 41 293 66 48 150
SD 12.7 – 19 – – 824 – – 115
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The mean clinical congestion score on admission was 5.6 
(SD 1.4) and decreased significantly over time to 1.3 (0.91) 
at T3 (Fig. 2). Other markers of clinical congestion, includ-
ing orthopnea, dyspnea, JVD, hepatojugular reflux and 
pulmonary rales, also showed similar significant changes 
between T1 and T3. The median Killip score was 2.
The mean IVC size on expiration showed no signifi-
cant change between T1 (1.9: SD 0.65) and T3 (2: SD 
0.50), nor did the IVC collapsibility index [T1 0.3 (0.19) 
versus T3 0.25 (0.16)] (Fig.  3). The mean number of B 
lines did decrease [T1 11 (6.1) versus T3 8.3 (5.5)], but 
this decrease did not reach statistical significance (Fig. 2). 
Analysis using non-parametric test for trends or ANOVA 
did not alter these conclusions.
Pearson correlations between JVP and HJR showed sig-
nificant correlations at T1 (0.58, p < 0.0001) and T2 (0.55, 
p = 0.0003). However, correlations between JVP or HJR 
and IVC size or collapsibility did not reach significance. 
Similarly, pulmonary rales and number of B lines across 
all time points did not show significant correlations. Uni-
variate and multivariate analysis did not show any clinical 
or ultrasound variables that correlate with hospital length 
of stay and 90-day mortality rate.
Ninety-eight percent of the IVC scans were interpret-
able and read; 1 out of 50 could not be read because of 
poor image quality. All LUS scans were interpretable and 
read offline. The quality of the scans was determined by 
expert opinion, an Intensive care specialist with advanced 
cardiac echo and formal training in lung ultrasound. 
There were no significant differences in the ultrasound 
variables between the two authors. Twenty-eight percent 
of patients did not complete all three time points.
Discussion
The present study showed no significant change in IVC 
size or collapsibility index despite significant improve-
ment in clinical signs of congestion in patients treated for 
acute decompensated heart failure. The results did show 
a trend toward significance for number of B lines; there 
was a 38% decrease in the number of B lines with the 
treatment of heart failure.
There are several explanations for the current data. 
This study enrolled patients upon admission to the car-
diac care unit, which occurred between hours and days 
after their presentation to the emergency department. 
Consequently, treatment for heart failure was already 
initiated in the emergency department prior to our first 
ultrasound assessment. Unfortunately, our hospital data-
base does not track delay to admission for these patients 
in particular. With this delay, the degree of hemodynamic 
congestion was likely diminished, and any appreciable 
changes in IVC size and B lines subsequent to the initial 
findings were too small to detect. This may indicate that 
IVC size and B lines clear rapidly with treatment and the 
sensitivity of this technique to detect such changes is on 
the level of hours in the acute setting. Additionally, the 
patients in the current study had a median Killip score of 
2, which indicates that this patient population had only 
mild heart failure.
In contrast to our results, Goonewardena et  al. [26] 
demonstrated significant reduction in IVC size and 
increases in collapsibility index with heart failure treat-
ment. This study found larger IVCs at admission (2.3 ver-
sus 1.9 cm in the current study). However, IVC size and 
collapsibility indices at discharge were identical between 
the two studies (2 cm in both studies). This may suggest 
that the greatest change in IVC size occurs early fol-
lowing initial therapy, and likely why the current study 
did not reach significance for this primary endpoint. 
However, IVC size as a surrogate for volume status has 
































































Fig. 2 Clinical exam findings at each time point
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the current data is that IVC size may not accurately rep-
resent hypervolemic states, and thus may not be useful in 
the management of decompensated heart failure.
Volpicelli et  al. [27] conducted a study where number 
of B lines was calculated at admission and discharge, 
and found significant clearing of B lines after treatment. 
However, this population had more severe heart fail-
ure than the current study. This study used an arbitrary 
clinical scale out of ten points to grade the clinical sever-
ity of heart failure which included the presence (1) or 
absence (0) of lower extremity edema, pulmonary rales 
and wheezing, jugular venous distension, orthopnea, 
high respiratory rates (>25  breaths/min) and low pulse 
oximeter saturation; median score was 8/10 on admis-
sion whereas in the current study, the mean CCS was 5.6 
out of 13. In another study, Gargani et al. [27] showed a 
significant reduction in B lines with treatment from 48 
on admission to 20 at discharge, compared to the cur-
rent study which showed a non-significant reduction of 
B lines from 11 to 8.3. Both these studies found a larger 
number of B lines on admission and sampled patients 
with more severe heart failure. This may indicate that 
LUS is a useful indicator of improvement in pulmonary 
congestion in patients with severe heart failure, but may 
fail to identify significant changes in pulmonary conges-
tion in patients with milder CHF.
Of note, Volpicelli [28] analyzed the B lines using a dif-
ferent method. Eleven regions were scanned, compared 
to eight regions in the current study. Additionally, a posi-
tive region was defined as number of B lines over 3, and 
they analyzed the data based on the number of positive 
regions as opposed to absolute number of B lines. How-
ever, we did not find a significant change even when our 
data were analyzed in a similar manner. There was no 
prospective strategy in the study protocol to quantify 
confluent B lines, and as a result, they were counted as 
a single B line. Although there is a suggested method to 
quantify confluent B lines by calculating the proportion 
of visualized pleural line/length of the confluent B lines 
[29], we felt that there is insufficient evidence to apply 
this technique at the current time. It is possible that we 
underestimated the overall quantity of B lines using this 
approach; however, this method was consistently used 
across all time points and should not affect the overall 
results.
There are several limitations in the current study. This 
was a small study with only 50 patients enrolled at a sin-
gle center. We did not formally estimate sample size as 
there were no reliable data to estimate effect size in this 
population. However, based on our results, a sample size 
of approximately 150 would be required to detect a sta-
tistically significant difference (α 0.05 and β 0.20) for B 
lines and a sample size of approximately 1000 would be 
required for change in IVC diameter.
Additionally, there was a high dropout rate with 28% of 
patients not completing all three time points. The clinical 
assessments were not blinded; resident authors perform-
ing these assessments knew at which time point each 
patient was being assessed, which could have introduced 
bias.
As mentioned above, since treatment was initiated 
early upon presentation and prior to recruitment, the 
ability to detect a potential decrease in IVC size and 
number of B lines may have be reduced. The clinical 
score would be less influenced as resolution of peripheral 
edema and crackles would lag, and the clinical history of 
orthopnea and PND is retrospective.
Assessment of volume status is challenging and 
point of care ultrasound may provide greater sensitiv-










































Fig. 3 Ultrasound findings at each time point
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congestion occurs. While this may be true for patients 
with more severe heart failure, the current study suggests 
that lung and vascular ultrasound in patients with less 
severe heart failure may not be sensitive enough to detect 
such small changes in hemodynamic congestion. As a 
result, serial POCUS may perform less well in patients 
with mild versus more severe heart failure. Based on the 
current results, IVC size or collapsibility index is not an 
accurate marker of improvement in hemodynamic con-
gestion. B lines may be a better marker of congestion as 
these did decrease with the treatment of heart failure as 
expected. The lack of statistical significance for the num-
ber of B lines may be a result of a small sample size, and 
a sampled population with less severe heart failure than 
previously published, and an initial small number of B 
lines. Another interpretation of our data is that given the 
significant correlation over time with clinical scores and 
not with ultrasound, it may suggest that clinical exam is 
more sensitive than ultrasound at detecting congestive 
symptoms, although this is hypothesis generating given 
the small sample size.
The current study is the only study to the authors’ 
knowledge, which directly compared lung and IVC ultra-
sound in the dynamic clinical setting of heart failure 
management after hospital admission. Further studies 
are warranted to better understand the utility of bedside 
ultrasound in patients with mild heart failure, and which 
ultrasound modality provides the most accurate assess-
ment of hemodynamic congestion for both diagnostic 
and prognostic purposes.
Conclusions
In conclusion, this study shows that vascular and lung 
ultrasound does not show significant changes with the 
management of heart failure in a hospitalized population 
with acute decompensated heart failure, although LUS 
shows a trend toward significance. This may indicate that 
vascular ultrasound parameters are less robust in patients 
with mild congestion and may show the greatest change 
during initial management.
Further larger scale studies are needed to explore how 
POCUS may be useful in the acute and sub-acute man-
agement of heart failure.
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